Table 2.
Patients Characteristics (n = 1677)
| Characteristic | No. of Patients | Percentage | |
|---|---|---|---|
| Age (Years) | |||
| Median | 50 | ||
| Range | 18–83 | ||
| Sex | |||
| Male | 1099 | 65.5 | |
| Females | 578 | 34.5 | |
| Primary Tumor | |||
| Head and Neck | 384 | 22.9 | |
| Lung | 373 | 22.2 | |
| Gastric | 191 | 11.4 | |
| Lymphoma | 191 | 11.4 | |
| Cervical | 121 | 7.2 | |
| Testicular | 104 | 6.2 | |
| Bladder | 77 | 4.6 | |
| Sarcoma | 45 | 2.7 | |
| Esophageal | 33 | 2.0 | |
| Others | 158 | 9.4 | |
| Khorana Risk Score | |||
| Low | 350 | 20.9 | |
| Intermediate | 1075 | 64.1 | |
| High | 252 | 15.0 | |
| Central Venous Catheter | |||
| Present | 303 | 18.1% | |
| Absent | 1374 | 81.9% | |
| Disease Stage | |||
| I | 56 | 3.3 | |
| II | 213 | 12.7 | |
| III | 487 | 29.0 | |
| IV | 857 | 51.1 | |
| Unstageable/Unknown | 64 | 3.8 | |